{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:07:57Z","timestamp":1773148077922,"version":"3.50.1"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11914-016-0320-5","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T06:27:03Z","timestamp":1471242423000},"page":"199-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease"],"prefix":"10.1007","volume":"14","author":[{"given":"S.","family":"Binks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,15]]},"reference":[{"key":"320_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bone.2014.06.011","volume":"66","author":"C Klop","year":"2014","unstructured":"Klop C, Welsing PM, Cooper C, et al. Mortality in British hip fracture patients, 2000\u20132010: a population-based retrospective cohort study. Bone. 2014;66:171\u20137.","journal-title":"Bone"},{"issue":"6914","key":"320_CR2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/bmj.307.6914.1248","volume":"307","author":"GS Keene","year":"1993","unstructured":"Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures. BMJ. 1993;307(6914):1248\u201350.","journal-title":"BMJ"},{"key":"320_CR3","doi-asserted-by":"crossref","unstructured":"Watts NB. GLOW investigators. Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Nat Rev Endocrinol. 2014;10(7):412\u201322. This study highlights medical co-morbidities that are associated with an increased risk of osteoporosis and fracture in the largest longitudinal study of bone health to date.","DOI":"10.1038\/nrendo.2014.55"},{"key":"320_CR4","unstructured":"National Institute for Health and Care Excellence. Osteoporosis: assessing the risk of fragility fracture (CG146). 2012 Aug [accessed 2016 Jan 3]. Available from URL: https:\/\/www.nice.org.uk\/guidance\/conditions-and-diseases\/diabetes-and-other-endocrinal--nutritional-and-metabolic-conditions\/osteoporosis ."},{"issue":"10","key":"320_CR5","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, et al. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359\u201381.","journal-title":"Osteoporos Int"},{"issue":"1","key":"320_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00198-013-2438-y","volume":"25","author":"CL Gregson","year":"2014","unstructured":"Gregson CL, Dennison EM, Compston JE, et al. Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int. 2014;25(1):85\u201395.","journal-title":"Osteoporos Int"},{"issue":"9648","key":"320_CR7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502\u201317.","journal-title":"Lancet"},{"issue":"2","key":"320_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.0b013e3182242d34","volume":"77","author":"SM Moen","year":"2011","unstructured":"Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holm\u00f8y T. Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome. Neurology. 2011;77(2):151\u20137.","journal-title":"Neurology"},{"issue":"10","key":"320_CR9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1177\/1352458512440206","volume":"18","author":"S Batista","year":"2012","unstructured":"Batista S, Teter B, Sequeira K, et al. Cognitive impairment is associated with reduced bone mass in multiple sclerosis. Mult Scler. 2012;18(10):1459\u201365.","journal-title":"Mult Scler"},{"issue":"2","key":"320_CR10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.semarthrit.2015.04.014","volume":"45","author":"RH Straub","year":"2015","unstructured":"Straub RH, Cutolo M, Pacifici R. Semin Arthritis Rheum. 2015;45(2):220\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"1\u20132","key":"320_CR11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2012.03.026","volume":"319","author":"S Josyula","year":"2012","unstructured":"Josyula S, Mehta BK, Karmon Y, et al. The nervous system\u2019s potential role in multiple sclerosis associated bone loss. J Neurol Sci. 2012;319(1\u20132):8\u201314.","journal-title":"J Neurol Sci"},{"issue":"6","key":"320_CR12","first-page":"544","volume":"2","author":"W Zhao","year":"2009","unstructured":"Zhao W, Liu Y, Cahill CM, Yang W, Rogers JT, Huang X. The role of T-cells in osteoporosis: an update. Int J Clin Exp Pathol. 2009;2(6):544\u201352.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"320_CR13","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","volume":"93","author":"C Ding","year":"2008","unstructured":"Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab. 2008;93(5):1952\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"320_CR14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jbmr.2037","volume":"29","author":"AL Eriksson","year":"2014","unstructured":"Eriksson AL, Mov\u00e9rare-Skrtic S, Ljunggren \u00d6, Karlsson M, M\u00ebllstrom D, Ohlsson C. High\u2010Sensitivity CRP is an independent risk factor for all fractures and vertebral fractures in elderly men: the MrOS Sweden study. J Bone Miner Res. 2014;29(2):418\u201323.","journal-title":"J Bone Miner Res"},{"issue":"6882","key":"320_CR15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Matsuo K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-\u03b2. Nature. 2002;416(6882):744\u20139.","journal-title":"Nature"},{"issue":"4","key":"320_CR16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/1352458509359723","volume":"16","author":"HJ Vogt","year":"2010","unstructured":"Vogt HJ, ten Kate J, Drent RJ, Polman CH, Hupperts R. Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers. Mult Scler. 2010;16(4):443\u20139.","journal-title":"Mult Scler"},{"issue":"10","key":"320_CR17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1359\/JBMR.040712","volume":"19","author":"MW Hamrick","year":"2004","unstructured":"Hamrick MW. Leptin, bone mass and the thrifty phenotype. J Bone Miner Res. 2004;19(10):1607\u201311.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"320_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/practneurol-2012-000435","volume":"13","author":"R Dobson","year":"2013","unstructured":"Dobson R, Yarnall A, Noyce AJ, Giovannoni G. Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes. Pract Neurol. 2013;13(2):70\u20139.","journal-title":"Pract Neurol"},{"key":"320_CR19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","volume":"7","author":"GC Ebers","year":"2008","unstructured":"Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7:268\u201377.","journal-title":"Lancet Neurol"},{"issue":"6","key":"320_CR20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ana.22678","volume":"70","author":"SV Ramagopalan","year":"2011","unstructured":"Ramagopalan SV, Dyment DA, Cader MZ, et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol. 2011;70(6):881\u20136.","journal-title":"Ann Neurol"},{"issue":"3","key":"320_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.23833","volume":"73","author":"M Ban","year":"2013","unstructured":"Ban M, Callier S, Mero IL, et al. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol. 2013;73(3):430\u20132.","journal-title":"Ann Neurol"},{"issue":"9","key":"320_CR22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"J Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44(9):1687\u201392.","journal-title":"Neurology"},{"issue":"4","key":"320_CR23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","volume":"51","author":"F Cosman","year":"1998","unstructured":"Cosman F, Nieves J, Komar BS, et al. Fracture history and bone loss in patients with MS. Neurology. 1998;51(4):1161\u20135.","journal-title":"Neurology"},{"issue":"10","key":"320_CR24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jocn.2010.01.044","volume":"17","author":"T Terzi","year":"2010","unstructured":"Terzi T, Terzi M, Tander B, Cant\u03cbrk F, Onar M. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. J Clin Neurosci. 2010;17(10):1260\u20134.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"320_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","volume":"23","author":"S Ozgocmen","year":"2005","unstructured":"Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardigoclu O, \u00d6zkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005;23(4):309\u201313.","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"320_CR26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00415-009-5337-6","volume":"257","author":"LH Steffensen","year":"2010","unstructured":"Steffensen LH, Mellgren SI, Kampman MT. Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol. 2010;257(3):410\u20138.","journal-title":"J Neurol"},{"issue":"9","key":"320_CR27","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","volume":"258","author":"LH Steffensen","year":"2011","unstructured":"Steffensen LH, J\u00f8rgensen L, Straume B, Mellgren SI, Kampman MT. Can Vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol. 2011;258(9):1624\u201331.","journal-title":"J Neurol"},{"issue":"9","key":"320_CR28","doi-asserted-by":"crossref","first-page":"e45703","DOI":"10.1371\/journal.pone.0045703","volume":"7","author":"SM Moen","year":"2012","unstructured":"Moen SM, Celius EG, Sandvik L, et al. Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study. PLoS One. 2012;7(9):e45703. Highlights the need to consider metabolic bone disease in early multiple sclerosis, before significant fixed disability has developed.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"320_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jns.2011.09.002","volume":"313","author":"N Triantafyllou","year":"2012","unstructured":"Triantafyllou N, Lambrinoudaki I, Thoda P, et al. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis. J Neurol Sci. 2012;313(1\u20132):137\u201341.","journal-title":"J Neurol Sci"},{"issue":"1","key":"320_CR30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1352458514538884","volume":"21","author":"Y Nilsag\u00e5rd","year":"2015","unstructured":"Nilsag\u00e5rd Y, Gunn H, Freeman J, et al. Falls in people with MS\u2014an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States. Mult Scler. 2015;21(1):92\u2013100.","journal-title":"Mult Scler"},{"issue":"7","key":"320_CR31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.42.7.1389","volume":"42","author":"RA Troiano","year":"1992","unstructured":"Troiano RA, Jotkowitz A, Cook SD, Bansil S, Zito G. Rate and types of fractures in corticosteroid-treated multiple sclerosis patients. Neurology. 1992;42(7):1389\u201391.","journal-title":"Neurology"},{"key":"320_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0404.2011.01548.x","volume":"191","author":"SM Moen","year":"2011","unstructured":"Moen SM, Celius EG, Nordsletten L, Holm\u00f8y T. Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis. Acta Neurol Scand Suppl. 2011;191:79\u201382.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"9","key":"320_CR33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107620","volume":"9","author":"R Mazumder","year":"2014","unstructured":"Mazumder R, Murchison S, Bourdette D, Cameron M. Falls in people with multiple sclerosis compared with falls in healthy controls. PLoS One. 2014;9(9), e107620.","journal-title":"PLoS One"},{"issue":"3","key":"320_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0269215508095087","volume":"23","author":"Y Nilsag\u00e5rd","year":"2009","unstructured":"Nilsag\u00e5rd Y, Lundholm C, Denison E, Gunnarsson LG. Predicting accidental falls in people with multiple sclerosis\u2014a longitudinal study. Clin Rehabil. 2009;23(3):259\u201369.","journal-title":"Clin Rehabil"},{"issue":"17","key":"320_CR35","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/WNL.0b013e3181beece8","volume":"73","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Cutter G, Tyry T, Vollmer T. A cross-sectional study of bone health in multiple sclerosis. Neurology. 2009;73(17):1394\u20138.","journal-title":"Neurology"},{"issue":"21","key":"320_CR36","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1212\/WNL.0000000000002146","volume":"85","author":"JK Haselkorn","year":"2015","unstructured":"Haselkorn JK, Hughes C, Rae-Grant A, et al. Summary of comprehensive systematic review: rehabilitation in multiple sclerosis. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2015;85(21):1896\u2013903.","journal-title":"Neurology"},{"issue":"6","key":"320_CR37","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1191\/1352458503ms966oa","volume":"9","author":"S T\u00fczun","year":"2003","unstructured":"T\u00fczun S, Altintas A, Karacan I, Tang\u00fcrek S, Saip S, Siva A. Bone status in multiple sclerosis: beyond corticosteroids. Mult Scler. 2003;9(6):600\u20134.","journal-title":"Mult Scler"},{"issue":"4","key":"320_CR38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/ene.12479","volume":"22","author":"M Tyblova","year":"2015","unstructured":"Tyblova M, Kalincik T, Zikan V, Havrdova E. Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis. Eur J Neurol. 2015;22(4):624\u201332.","journal-title":"Eur J Neurol"},{"issue":"11","key":"320_CR39","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology"},{"issue":"2","key":"320_CR40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","volume":"10","author":"B Weinstock-Guttman","year":"2004","unstructured":"Weinstock-Guttman B, Gallagher E, Baier M, et al. Risk of bone loss in men with multiple sclerosis. Mult Scler. 2004;10(2):170\u20135.","journal-title":"Mult Scler"},{"issue":"4","key":"320_CR41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.33549\/physiolres.932299","volume":"61","author":"V Zik\u00e1n","year":"2012","unstructured":"Zik\u00e1n V, T\u00fdblova M, Ra\u0161ka Jr I, et al. Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids. Physiol Res. 2012;61(4):405\u201317.","journal-title":"Physiol Res"},{"issue":"7","key":"320_CR42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2005.00988.x","volume":"12","author":"M Zorzon","year":"2005","unstructured":"Zorzon M, Zivadinov R, Locatelli L, et al. Long-term effects of intravenous high dose methylprednisolone pulses in bone mineral density in patients with multiple sclerosis. Eur J Neurol. 2005;12(7):550\u20136.","journal-title":"Eur J Neurol"},{"issue":"12","key":"320_CR43","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s00198-011-1644-8","volume":"22","author":"JC Gibson","year":"2011","unstructured":"Gibson JC, Summers GD. Bone health in multiple sclerosis. Osteoporos Int. 2011;22(12):2935\u201349.","journal-title":"Osteoporos Int"},{"issue":"5","key":"320_CR44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10072-011-0623-3","volume":"32","author":"C Sioka","year":"2011","unstructured":"Sioka C, Papkonstantinou S, Fotopoulos A, et al. Bone mineral density in ambulatory patients with multiple sclerosis. Neurol Sci. 2011;32(5):819\u201324.","journal-title":"Neurol Sci"},{"issue":"8914","key":"320_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","volume":"344","author":"AK Gough","year":"1994","unstructured":"Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344(8914):23\u20137.","journal-title":"Lancet"},{"key":"320_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-6-19","volume":"6","author":"F Then Bergh","year":"2006","unstructured":"Then Bergh F, K\u03cbmpfel T, Schumann E, et al. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis\u2014reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol. 2006;6:19.","journal-title":"BMC Neurol"},{"issue":"7","key":"320_CR47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1474-4422(10)70132-0","volume":"9","author":"M Ravnborg","year":"2010","unstructured":"Ravnborg M, S\u00f8rensen PS, Andersson M, et al. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. Lancet Neurol. 2010;9(7):672\u201380.","journal-title":"Lancet Neurol"},{"issue":"12","key":"320_CR48","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1177\/1352458514566417","volume":"21","author":"A Olsson","year":"2015","unstructured":"Olsson A, Oturai DB, S\u00f8rensen PS, Oturai PS, Oturai AB. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis. Mult Scler. 2015;21(12):1557\u201365. Indicates that short pulsed corticosteroids used for MS relapse are likely to be safe from a BMD point of view.","journal-title":"Mult Scler"},{"issue":"2","key":"320_CR49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900309","volume":"61","author":"CA Formica","year":"1997","unstructured":"Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R. Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcif Tissue Int. 1997;61(2):129\u201333.","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"320_CR50","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.418","volume":"26","author":"M Bazelier","year":"2011","unstructured":"Bazelier M, van Staa T, Uitdehaag MJ, et al. The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res. 2011;26(9):2271\u20139.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"320_CR51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1468-1331.2006.01375.x","volume":"13","author":"P Ce","year":"2006","unstructured":"Ce P, Gedizlioglu M, Gelal F, Coban P, Ozbek G. Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. Eur J Neurol. 2006;13(8):857\u201361.","journal-title":"Eur J Neurol"},{"issue":"6","key":"320_CR52","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10072-011-0914-8","volume":"33","author":"MA Sahraian","year":"2012","unstructured":"Sahraian MA, Yadegari S, Azarpajouh R, Forughipour M. Avascular necrosis of the femoral head in multiple sclerosis: report of five patients. Neurol Sci. 2012;33(6):1443\u20136.","journal-title":"Neurol Sci"},{"issue":"6440","key":"320_CR53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.289.6440.309","volume":"289","author":"S Cocksedge","year":"1984","unstructured":"Cocksedge S, Freestone S, Martin JF. Unrecognised femoral fractures in patients with paraplegia due to multiple sclerosis. Br Med J (Clin Res Ed). 1984;289(6440):309.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"11","key":"320_CR54","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1177\/1352458512442755","volume":"18","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, Bentzen J, Vestergaard P, et al. The risk of fracture in incident multiple sclerosis patients: the Danish national health registers. Mult Scler. 2012;18(11):1609\u201316.","journal-title":"Mult Scler"},{"issue":"24","key":"320_CR55","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/WNL.0b013e318259e0ff","volume":"78","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, van Staa TP, Uitdehaag BM, et al. Risk of fractures in patients with multiple sclerosis. A population-based cohort study. Neurology. 2012;78(24):1967\u201373. A large population-based study examining the risk of fracture in patients with MS, leading to the development of a novel method of estimating fracture risk in this population.","journal-title":"Neurology"},{"issue":"18","key":"320_CR56","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1212\/01.wnl.0000422676.74031.07","volume":"79","author":"R Dobson","year":"2012","unstructured":"Dobson R, Ramagopalan S, Giovannoni G. Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology. 2012;79(18):1934\u20135. Comment on: Risk of fractures in patients with multiple sclerosis: a population-based cohort study. [Neurology 2012].","journal-title":"Neurology"},{"issue":"9319","key":"320_CR57","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359(9319):1761\u20137.","journal-title":"Lancet"},{"issue":"1","key":"320_CR58","first-page":"19","volume":"12","author":"A Ayatollahi","year":"2013","unstructured":"Ayatollahi A, Mohajeri-Tehrani MR, Nafissi S. Factors affecting bone mineral density in multiple sclerosis patients. Iran J Neurol. 2013;12(1):19\u201322.","journal-title":"Iran J Neurol"},{"issue":"6","key":"320_CR59","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","volume":"50","author":"EM Dennison","year":"2012","unstructured":"Dennison EM, Compston JE, Flahive J, et al. Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2012;50(6):1288\u201393.","journal-title":"Bone"},{"key":"320_CR60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2377-12-135","volume":"12","author":"SV Ramagopalan","year":"2012","unstructured":"Ramagopalan SV, Seminog O, Goldacre R, Goldacre MJ. Risk of fractures in patients with multiple sclerosis: record-linkage study. BMC Neurol. 2012;12:135.","journal-title":"BMC Neurol"},{"key":"320_CR61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/JMDH.S54786","volume":"7","author":"RK Bhattacharya","year":"2014","unstructured":"Bhattacharya RK, Vaishnav N, Dubinsky RM. Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the nationwide inpatient sample. J Multidiscip Healthc. 2014;7:119\u201322.","journal-title":"J Multidiscip Healthc"},{"key":"320_CR62","unstructured":"FRAX\u00ae WHO Fracture Risk Assessment Tool [on-line] [accessed 2016 Jan 7]. Available from URL: https:\/\/www.shef.ac.uk\/FRAX\/index.aspx"},{"key":"320_CR63","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ. 2012;344, e3427.","journal-title":"BMJ"},{"issue":"9","key":"320_CR64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.0b013e318266faae","volume":"79","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, van Staa TP, Uitedehaag BM, et al. A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis. Neurology. 2012;79(9):922\u20138.","journal-title":"Neurology"},{"key":"320_CR65","doi-asserted-by":"crossref","unstructured":"Dobson R, Leddy SG, Gangadharan S, Giovannoni G. Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems. BMJ Open. 2013; 3 (3). Highlights the deficit in fracture risk calculators for the MS population.","DOI":"10.1136\/bmjopen-2012-002508"},{"issue":"11","key":"320_CR66","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1177\/1352458512453362","volume":"18","author":"R Dobson","year":"2012","unstructured":"Dobson R, Ramagopalan S, Giovannoni G. Bone health and multiple sclerosis. Mult Scler. 2012;18(11):1522\u20138.","journal-title":"Mult Scler"},{"issue":"1","key":"320_CR67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11845-008-0253-9","volume":"178","author":"M Shuhaibar","year":"2009","unstructured":"Shuhaibar M, McKenna MJ, Au-Yeong M, Redmond JM. Favourable effect of immunomodulatory therapy on bone mineral density in multiple sclerosis. Ir J Med Sci. 2009;178(1):43\u20135.","journal-title":"Ir J Med Sci"},{"issue":"5","key":"320_CR68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1352458506070605","volume":"12","author":"B Weinstock-Guttman","year":"2006","unstructured":"Weinstock-Guttman B, Hong J, Santos R, et al. Interferon-\u03b2 modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. Mult Scler. 2006;12(5):541\u201350.","journal-title":"Mult Scler"},{"issue":"12","key":"320_CR69","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.bcp.2009.01.007","volume":"77","author":"AK Abraham","year":"2009","unstructured":"Abraham AK, Ramanathan M, Weinstock-Guttman B, Mager DE. Mechanisms of interferon-\u03b2 effects on bone homeostasis. Biochem Pharmacol. 2009;77(12):1757\u201362.","journal-title":"Biochem Pharmacol"},{"key":"320_CR70","volume":"9","author":"LD Gillespie","year":"2012","unstructured":"Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;9, CD007146.","journal-title":"Cochrane Database Syst Rev"},{"key":"320_CR71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ane.12028","volume":"195","author":"T Holm\u00f8y","year":"2012","unstructured":"Holm\u00f8y T, Torkildsen \u00d8, Myhr K-M, L\u00f8ken-Amsrud KI. Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. Acta Neurol Scand Suppl. 2012;195:63\u20139.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"23","key":"320_CR72","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy MC, Arlot MF, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327(23):1637\u201342.","journal-title":"N Engl J Med"},{"key":"320_CR73","doi-asserted-by":"crossref","first-page":"h4183","DOI":"10.1136\/bmj.h4183","volume":"351","author":"V Tai","year":"2015","unstructured":"Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015;351:h4183.","journal-title":"BMJ"},{"key":"320_CR74","doi-asserted-by":"crossref","first-page":"h4580","DOI":"10.1136\/bmj.h4580","volume":"351","author":"MJ Bolland","year":"2015","unstructured":"Bolland MJ, Leung W, Tai V, et al. Calcium intake and risk of fracture: systematic review. BMJ. 2015;351:h4580.","journal-title":"BMJ"},{"key":"320_CR75","doi-asserted-by":"crossref","first-page":"h3170","DOI":"10.1136\/bmj.h3170","volume":"351","author":"A Grey","year":"2015","unstructured":"Grey A, Bolland M. Web of industry, advocacy and academia in the management of osteoporosis. BMJ. 2015;351:h3170.","journal-title":"BMJ"},{"issue":"9996","key":"320_CR76","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386(9996):896\u2013912.","journal-title":"Lancet"},{"issue":"7","key":"320_CR77","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/01.WNL.0000140706.52798.BE","volume":"63","author":"LM Lau de","year":"2004","unstructured":"de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam study. Neurology. 2004;63(7):1240\u20134.","journal-title":"Neurology"},{"issue":"4","key":"320_CR78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s004150200032","volume":"249","author":"A Schrag","year":"2002","unstructured":"Schrag A, Ben-Schlomo Y, Quinn N. How common are complications of Parkinson\u2019s disease? J Neurol. 2002;249(4):419\u201323.","journal-title":"J Neurol"},{"issue":"2","key":"320_CR79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10072-004-0232-5","volume":"25","author":"E Martignoni","year":"2004","unstructured":"Martignoni E, Godi L, Citterio A, et al. Comorbid disorders and hospitalisation in Parkinson\u2019s disease: a prospective study. Neurol Sci. 2004;25(2):66\u201371.","journal-title":"Neurol Sci"},{"issue":"4","key":"320_CR80","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/mds.20347","volume":"20","author":"CL Wielinski","year":"2005","unstructured":"Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson\u2019s disease and other Parkinsonian syndromes. Mov Disord. 2005;20(4):410\u20135.","journal-title":"Mov Disord"},{"issue":"8","key":"320_CR81","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1445-5994.2006.01123.x","volume":"36","author":"JA Temlett","year":"2006","unstructured":"Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson\u2019s disease. Intern Med J. 2006;36(8):524\u20136.","journal-title":"Intern Med J"},{"issue":"5","key":"320_CR82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ageing\/15.5.285","volume":"15","author":"O Johnell","year":"1986","unstructured":"Johnell O, Sernbo I. Health and social status in patients with hip fractures and controls. Age Ageing. 1986;15(5):285\u201391.","journal-title":"Age Ageing"},{"issue":"1","key":"320_CR83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jnnp.66.1.64","volume":"66","author":"Y Sato","year":"1999","unstructured":"Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1\u03b1-hydroxyvitamin D3 in elderly patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;66(1):64\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"320_CR84","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.20825","volume":"21","author":"Y Sato","year":"2006","unstructured":"Sato Y, Iwamoto J, Kanoko T, Satoh K. Alendronate and Vitamin D2 for prevention of hip fracture in Parkinson\u2019s disease: a randomized controlled trial. Mov Disord. 2006;21(7):924\u20139.","journal-title":"Mov Disord"},{"issue":"12","key":"320_CR85","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000257089.50476.92","volume":"68","author":"Y Sato","year":"2007","unstructured":"Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology. 2007;68(12):911\u20135.","journal-title":"Neurology"},{"issue":"5","key":"320_CR86","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.49.5.1273","volume":"49","author":"Y Sato","year":"1997","unstructured":"Sato Y, Kikuyama M, Oizumi K. High prevalence of Vitamin D deficiency and reduced bone mass in Parkinson\u2019s disease. Neurology. 1997;49(5):1273\u20138.","journal-title":"Neurology"},{"issue":"5","key":"320_CR87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.parkreldis.2009.02.009","volume":"15","author":"M Invernizzi","year":"2009","unstructured":"Invernizzi M, Carda S, Viscontini GS, Cisari C. Osteoporosis in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2009;15(5):339\u201346.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"320_CR88","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015;14(6):625\u201339.","journal-title":"Lancet Neurol"},{"key":"320_CR89","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2377-10-124","volume":"10","author":"AF Jaafar","year":"2010","unstructured":"Jaafar AF, Gray WK, Porter B, Turnbull EJ, Walker RW. A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson\u2019s disease. BMC Neurol. 2010;10:124.","journal-title":"BMC Neurol"},{"issue":"2","key":"320_CR90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(00)00458-5","volume":"182","author":"Y Sato","year":"2001","unstructured":"Sato Y, Kaji M, Tsuru T, Oizumi K. Risk factors for hip fracture among elderly patients with Parkinson\u2019s disease. J Neurol Sci. 2001;182(2):89\u201393.","journal-title":"J Neurol Sci"},{"issue":"8","key":"320_CR91","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 2012;11(8):697\u2013707.","journal-title":"Lancet Neurol"},{"issue":"6","key":"320_CR92","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afp137","volume":"38","author":"S Abou-Raya","year":"2009","unstructured":"Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson\u2019s disease. Age Ageing. 2009;38(6):675\u201380.","journal-title":"Age Ageing"},{"issue":"1","key":"320_CR93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/WNL.60.1.87","volume":"60","author":"JC Pressley","year":"2003","unstructured":"Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology. 2003;60(1):87\u201393.","journal-title":"Neurology"},{"issue":"9","key":"320_CR94","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.20946","volume":"21","author":"LJ Melton 3rd","year":"2006","unstructured":"Melton 3rd LJ, Leibson CL, Achenbach SJ, et al. Fracture risk after the diagnosis of Parkinson\u2019s disease: influence of concomitant dementia. Mov Disord. 2006;21(9):1361\u20137.","journal-title":"Mov Disord"},{"issue":"2","key":"320_CR95","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yexmp.2015.02.004","volume":"98","author":"HA Shirazi","year":"2015","unstructured":"Shirazi HA, Rasouli J, Ciric B, Rostami A, Zhang GX. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol. 2015;98(2):240\u20135.","journal-title":"Exp Mol Pathol"},{"issue":"9","key":"320_CR96","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1532-5415.2005.53464.x","volume":"53","author":"HA Fink","year":"2005","unstructured":"Fink HA, Kuskowski MA, Orwoll ES, Cauley JA, Ensrud KE, Osteoporotic Fractures in Men Study Group. Association between Parkinson\u2019s disease and low bone density and falls in older men: the osteoporotic fractures in men study. J Am Geriatr Soc. 2005;53(9):1559\u201364.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"320_CR97","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00198-008-0583-5","volume":"19","author":"JL Schneider","year":"2008","unstructured":"Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR, Study of Osteoporotic Fractures (SOF) Research Group. The association of Parkinson\u2019s disease with bone mineral density and fracture in older women. Osteoporos Int. 2008;19(7):1093\u20137.","journal-title":"Osteoporos Int"},{"issue":"13","key":"320_CR98","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archinternmed.2010.173","volume":"170","author":"DJ Llewellyn","year":"2010","unstructured":"Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135\u201341.","journal-title":"Arch Intern Med"},{"issue":"24","key":"320_CR99","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.0000000000001080","volume":"83","author":"ED Toffanello","year":"2014","unstructured":"Toffanello ED, Coin A, Perissinotto E, et al. Vitamin D deficiency predicts cognitive decline in older men and women. Neurology. 2014;83(24):2292\u20138.","journal-title":"Neurology"},{"issue":"10","key":"320_CR100","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","volume":"65","author":"ML Evatt","year":"2008","unstructured":"Evatt ML, DeLong MR, Khazai N, et al. Prevalence of Vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65(10):1348\u201352.","journal-title":"Arch Neurol"},{"issue":"19","key":"320_CR101","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJM199105093241905","volume":"324","author":"JA Grisso","year":"1991","unstructured":"Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med. 1991;324(19):1326\u201331.","journal-title":"N Engl J Med"},{"issue":"9","key":"320_CR102","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mds.20485","volume":"20","author":"H Woodford","year":"2005","unstructured":"Woodford H, Walker R. Emergency hospital admissions in idiopathic Parkinson\u2019s disease. Mov Disord. 2005;20(9):1104\u20138.","journal-title":"Mov Disord"},{"issue":"4","key":"320_CR103","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/jnnp.2005.074070","volume":"77","author":"DR Williams","year":"2006","unstructured":"Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry. 2006;77(4):468\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"320_CR104","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427\u201342.","journal-title":"Neurology"},{"issue":"1","key":"320_CR105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2014-000849","volume":"15","author":"K Ali","year":"2015","unstructured":"Ali K, Morris HR. Parkinson\u2019s disease: chameleons and mimics. Pract Neurol. 2015;15(1):14\u201325.","journal-title":"Pract Neurol"},{"issue":"2","key":"320_CR106","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00002826-198904000-00009","volume":"12","author":"WC Koller","year":"1989","unstructured":"Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson\u2019s disease. Clin Neuropharmacol. 1989;12(2):98\u2013105.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"320_CR107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/ageing\/30.1.47","volume":"30","author":"A Ashburn","year":"2001","unstructured":"Ashburn A, Stack E, Pickering RM, Ward CD. A community-dwelling sample of people with Parkinson\u2019s disease: characteristics of fallers and non-fallers. Age Ageing. 2001;30(1):47\u201352.","journal-title":"Age Ageing"},{"issue":"11","key":"320_CR108","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00415-005-0855-3","volume":"252","author":"Y Balash","year":"2005","unstructured":"Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson\u2019s disease. Frequency, impact and identifying factors. J Neurol. 2005;252(11):1310\u20135.","journal-title":"J Neurol"},{"issue":"12","key":"320_CR109","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/mds.21155","volume":"21","author":"ML Eng","year":"2006","unstructured":"Eng ML, Lyons KE, Pahwa R. Prevalence of bone mineral density screening in Parkinson\u2019s disease clinic outpatients. Mov Disord. 2006;21(12):2265\u20136.","journal-title":"Mov Disord"},{"issue":"11","key":"320_CR110","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s004150170047","volume":"248","author":"BR Bloem","year":"2001","unstructured":"Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson\u2019s disease. J Neurol. 2001;248(11):950\u20138.","journal-title":"J Neurol"},{"issue":"6","key":"320_CR111","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jnnp.72.6.721","volume":"72","author":"BH Wood","year":"2002","unstructured":"Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson\u2019s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72(6):721\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"320_CR112","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2013.09.024","volume":"20","author":"KY Cheng","year":"2014","unstructured":"Cheng KY, Lin WC, Chang WN, et al. Factors associated with fall-related fractures in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20(1):88\u201392. Provides background into fracture risk in PD.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"320_CR113","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00198-010-1455-3","volume":"22","author":"ME Arbouw","year":"2011","unstructured":"Arbouw ME, Movig KL, van Staa TP, Egberts AC, Souverein PC, de Vries F. Dopaminergic drugs and the risk of hip or femur fracture: a population based study. Osteoporos Int. 2011;22(7):2197\u2013204.","journal-title":"Osteoporos Int"},{"issue":"12","key":"320_CR114","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/mds.20643","volume":"20","author":"B Wood","year":"2005","unstructured":"Wood B, Walker R. Osteoporosis in Parkinson\u2019s disease. Mov Disord. 2005;20(12):1636\u201340.","journal-title":"Mov Disord"},{"issue":"2","key":"320_CR115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00223-009-9327-6","volume":"86","author":"SH Lee","year":"2010","unstructured":"Lee SH, Kim MJ, Kim BJ, et al. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson\u2019s disease. Calcif Tissue Int. 2010;86(2):132\u201341.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"320_CR116","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.parkreldis.2007.01.006","volume":"13","author":"M Brandt-Christiansen","year":"2007","unstructured":"Brandt-Christiansen M, Lopez AG, Nilsson FM, Andersen PK, Kessing LV. Parkinson\u2019s disease and antidepressant drug treatment\u2014a case register study. Parkinsonism Relat Disord. 2007;13(7):406\u201310.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"320_CR117","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00198-009-0849-6","volume":"20","author":"MW Brand van den","year":"2009","unstructured":"van den Brand MW, Samson MM, Pouwels S, et al. Use of anti-depressants and risk of fracture of the hip or femur. Osteoporos Int. 2009;20(10):1705\u201313.","journal-title":"Osteoporos Int"},{"issue":"11","key":"320_CR118","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.25073","volume":"27","author":"RK Bhattacharya","year":"2012","unstructured":"Bhattacharya RK, Dubinsky RM, Lai SM, Dubinsky H. Is there an increased risk of hip fracture in Parkinson\u2019s disease? A nationwide inpatient sample. Mov Disord. 2012;27(11):1440\u20133.","journal-title":"Mov Disord"},{"issue":"10","key":"320_CR119","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/jnnp-2013-307307","volume":"85","author":"KM Torsney","year":"2014","unstructured":"Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ. Bone health in Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85(10):1159\u201366.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"320_CR120","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00198-008-0584-4","volume":"19","author":"HA Fink","year":"2008","unstructured":"Fink HA, Kuskowski MA, Taylor BC, et al. Association of Parkinson\u2019s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int. 2008;19(9):1277\u201382.","journal-title":"Osteoporos Int"},{"issue":"3","key":"320_CR121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00006231-199403000-00010","volume":"15","author":"CH Kao","year":"1994","unstructured":"Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH. Bone mineral density in patients with Parkinson\u2019s disease measured by dual photon absorptiometry. Nucl Med Commun. 1994;15(3):173\u20137.","journal-title":"Nucl Med Commun"},{"issue":"4","key":"320_CR122","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ageing\/24.4.326","volume":"24","author":"H Taggart","year":"1995","unstructured":"Taggart H, Crawford V. Reduced bone mineral density of the hip in elderly patients with Parkinson\u2019s disease. Age Ageing. 1995;24(4):326\u20138.","journal-title":"Age Ageing"},{"issue":"4","key":"320_CR123","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0404.2007.00875.x","volume":"116","author":"B Loref\u00e4lt","year":"2007","unstructured":"Loref\u00e4lt B, Toss G, Granaries AK. Bone mass in elderly patients with Parkinson\u2019s disease. Acta Neurol Scand. 2007;116(4):248\u201354.","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"320_CR124","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00296-008-0632-6","volume":"28","author":"A Bezza","year":"2008","unstructured":"Bezza A, Ouzzif Z, Naji H, et al. Prevalence and risk factors of osteoporosis in patients with Parkinson\u2019s disease. Rheumatol Int. 2008;28(12):1205\u20139.","journal-title":"Rheumatol Int"},{"issue":"3","key":"320_CR125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00415-012-6697-x","volume":"260","author":"F Bos van den","year":"2013","unstructured":"van den Bos F, Speelman AD, van Nimwegen M, et al. Bone mineral density and vitamin D status in Parkinson\u2019s disease patients. J Neurol. 2013;260(3):754\u201360.","journal-title":"J Neurol"},{"issue":"1","key":"320_CR126","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bone.2012.09.013","volume":"52","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Shen L, Ji HF. Osteoporosis risk and bone mineral density levels in patients with Parkinson\u2019s disease: a meta-analysis. Bone. 2013;52(1):498\u2013505.","journal-title":"Bone"},{"issue":"1","key":"320_CR127","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ageing\/21.1.32","volume":"21","author":"O Johnell","year":"1992","unstructured":"Johnell O, Melton 3rd LJ, Atkinson EJ, O\u2019Fallon M, Kurland LT. Fracture risk in patients with Parkinsonism: a population-based study in Olmsted County, Minnesota. Age Ageing. 1992;21(1):32\u20138.","journal-title":"Age Ageing"},{"issue":"1","key":"320_CR128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ageing\/afh203","volume":"34","author":"RW Genever","year":"2005","unstructured":"Genever RW, Downes TW, Medcalf P. Fracture rates in Parkinson\u2019s disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing. 2005;34(1):21\u20134.","journal-title":"Age Ageing"},{"issue":"8","key":"320_CR129","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00198-013-2300-2","volume":"24","author":"S Pouwels","year":"2013","unstructured":"Pouwels S, Bazelier MT, de Boer A, et al. Risk of fracture in patients with Parkinson\u2019s disease. Osteoporos Int. 2013;24(8):2283\u201390.","journal-title":"Osteoporos Int"},{"key":"320_CR130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00003086-198005000-00031","volume":"148","author":"L Coughlin","year":"1980","unstructured":"Coughlin L, Templeton J. Hip fractures in patients with Parkinson\u2019s disease. Clin Orthop Relat Res. 1980;148:192\u20135.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"320_CR131","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00005373-198302000-00004","volume":"23","author":"I Eventov","year":"1983","unstructured":"Eventov I, Moreno M, Geller E, Tardiman R, Salama R. Hip fractures in patients with Parkinson\u2019s syndrome. J Trauma. 1983;23(2):98\u2013101.","journal-title":"J Trauma"},{"key":"320_CR132","doi-asserted-by":"crossref","unstructured":"Turcotte R, Godin C, Duchesne R, Jodoin A. Hip fractures and Parkinson\u2019s disease. A clinical review of 94 fractures treated surgically. Clin Orthop Relat Res. 1990; (256):132\u20136.","DOI":"10.1097\/00003086-199007000-00020"},{"issue":"10","key":"320_CR133","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.injury.2005.11.013","volume":"37","author":"VJ Clubb","year":"2006","unstructured":"Clubb VJ, Clubb SE, Buckley S. Parkinson\u2019s disease patients who fracture their neck of femur: a review of outcome data. Injury. 2006;37(10):929\u201334.","journal-title":"Injury"},{"issue":"3","key":"320_CR134","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mds.25297","volume":"28","author":"RW Walker","year":"2013","unstructured":"Walker RW, Chaplin A, Hancock RL, Rutherford R, Gray WK. Hip fractures in people with idiopathic Parkinson\u2019s disease: incidence and outcomes. Mov Disord. 2013;28(3):334\u201340.","journal-title":"Mov Disord"},{"issue":"6","key":"320_CR135","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00415-014-7333-8","volume":"261","author":"S Shribman","year":"2014","unstructured":"Shribman S, Torsney K, Noyce AJ, Giovannoni G, Fearnley J, Dobson R. A service development study of the assessment and management of fracture risk in Parkinson\u2019s disease. J Neurol. 2014;261(6):1153\u20139.","journal-title":"J Neurol"},{"issue":"1","key":"320_CR136","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ageing\/afu122","volume":"44","author":"V Lyell","year":"2015","unstructured":"Lyell V, Henderson E, Devine M, Gregson C. Assessment and management of fracture risk in patients with Parkinson\u2019s disease. Age Ageing. 2015;44(1):34\u201341.","journal-title":"Age Ageing"},{"issue":"5","key":"320_CR137","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mds.21922","volume":"23","author":"VA Goodwin","year":"2008","unstructured":"Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2008;23(5):631\u201340.","journal-title":"Mov Disord"},{"issue":"18","key":"320_CR138","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809\u201322.","journal-title":"N Engl J Med"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0320-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-016-0320-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-016-0320-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T23:46:18Z","timestamp":1657064778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-016-0320-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,15]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1007\/s11914-016-0320-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,15]]}}}